Funder
National Natural Science Foundation of China
Shanghai Rising-Star Program
Clinical Research Plan of SHDC
Publisher
Springer Science and Business Media LLC
Reference43 articles.
1. Gelsomino F, Balsano R, De Lorenzo S, Garajova I. Small bowel adenocarcinoma: from molecular insights to clinical management. Curr Oncol. 2022;29(2):1223–36.
2. Turpin A, El Amrani M, Zaanan A. Localized Small Bowel Adenocarcinoma Management Evidence Summary. Cancers. 2022;14(12):2892.
3. Teufel A, Meindl NM, Hosel P, Gerken M, Roig A. Characteristics and outcome of patients with small bowel adenocarcinoma (SBA). J Cancer Res Clin Oncol. 2022;39(11):688–94.
4. Dabaja BS, Suki D, Pro B, Bonnen M, Ajani J. Adenocarcinoma of the small bowel: presentation, prognostic factors, and outcome of 217 patients. Cancer. 2004;101(3):518–26.
5. Halfdanarson TR, McWilliams RR, Donohue JH, Quevedo JF. A single-institution experience with 491 cases of small bowel adenocarcinoma. Am J Surg. 2010;199(6):797–803.